Glutamatergic Modulation of Disordered Alcohol Use
NCT02539511
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Alcohol Dependence
Interventions
DRUG:
CI-581a
DRUG:
CI-581b
BEHAVIORAL:
Motivational Enhancement Therapy (MET)
Sponsor
New York State Psychiatric Institute
Collaborators
[object Object]